National Barley Foods Council and BGLife Barley promote high-fiber diet
SPOKANE, Wash. The National Barley Foods Council and BGLife Barley are joining forces to promote awareness of the health benefits of fiber. Whole grain, high-fiber diets may help control and prevent Type 2 diabetes and pre-diabetes.
In accordance with National Diabetes Month in November, BGLife Barley is developing new grain products with higher amounts of soluble fiber. Its latest creation is Heart Balance Cereal, a completely whole-grain barley cereal. “A single serving of Heart Balance Cereal contains 50 percent more total dietary fiber and half the fat of oatmeal,” says Dr. Christine Fastnaught, technical manager at BGLife Barley. “Most importantly, just one serving of this cereal contain three grams of beta-glucan soluble fiber.”
Beta-glucan boasts many healthful attributes, including cholesterol reduction and weight control It also is an aid in establishing healthy blood sugar and blood pressure. A study in Nutrition Research and the Journal of the American College of Nutrition found that foods containing barley reduced glucose and insulin responses, and a study in the Diabetes Research and Clinical Practice Journal reported a 30 percent decrease in average blood glucose level in Type 2 diabetics who ate 18 grams of soluble fiber per day.
Nerviano partners with Genentech to develop anticancer drugs
NEW YORK A company that develops cancer drugs has announced a multi-year collaboration with Genentech.
Nerviano Medical Sciences said that it would collaborate with South San Francisco, Calif.-based Genentech to search for antibody drug compounds to develop anticancer drugs. It is the second agreement between Genentech and NMS in less than a year, NMS said.
Genentech will have exclusive rights to fully develop and commercialize licensed products, while NMS will primarily synthesize and manufacture drug reagents.
More Americans cutting back on prescription medications
NEW YORK Economic difficulties are causing more Americans to forego prescription drugs, according to The New York Times.
Costs for housing and food are trumping costs for drugs, and some patients have stopped taking drugs for chronic conditions such as osteoporosis and high cholesterol. Some drug makers have reported decreases in sales of certain drugs, while IMS Health has reported reductions in prescriptions being dispensed.
The Times reported that the trend could cause increases in complications from chronic disease.